Inventor · disambiguated record
Alleyn Thomas Plowright
Also filed as: PLOWRIGHT ALLEYN · PLOWRIGHT ALLEYN T · PLOWRIGHT ALLEYN THOMAS
12 granted patents·11 pending applications·38 citations·filing 2001–2024
88Inventor score
Files withASTRAZENECA AB12BIRCH ALAN MARTIN3HARVARD COLLEGE2ASTRAZENECA UK LTD1BENNETT STUART NORMAN LILE1
Top patents by PatentIndex Score
23 records- 0192US11691978B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2021·Granted Jul 4, 2023·2 cites·5 claims
- 0288US7795283B2Oxadiazole derivative as DGAT inhibitorsASTRAZENECA AB·Filed 2005·Granted Sep 14, 2010·15 cites·6 claims
- 0387US10508119B2Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2018·Granted Dec 17, 2019·5 cites·18 claims
- 0486US11001589B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2019·Granted May 11, 2021·4 cites·11 claims
- 0586US10183947B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2016·Granted Jan 22, 2019·5 cites·9 claims
- 0683US2024317767A1Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0782US12024523B2Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitorsASTRAZENECA AB·Filed 2023·Granted Jul 2, 2024·0 cites·15 claims
- 0870US7659279B2Quinazoline derivatives and their use in the treatment of cancerASTRAZENECA AB·Filed 2004·Granted Feb 9, 2010·5 cites·16 claims
- 0965US6809099B2Saframycins, analogues and uses thereofHARVARD COLLEGE·Filed 2001·Granted Oct 26, 2004·2 cites·33 claims
- 1064US2025170103A14-(6-oxo-2-(trifluoromethyl)-3,6-dihydrochromeno[7,8-d]imidazol-8-yl)benzonitrile for use in the treatment of diseases and conditions associated with movement disordersONTRACK THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1161US2007112008A1Saframycins, analogues and uses thereofMYERS ANDREW G·Filed 2006·Application pending·0 cites
- 1254US8003676B21,3,4-oxadiazole derivatives as DGAT1 inhibitorsASTRAZENECA AB·Filed 2007·Granted Aug 23, 2011·0 cites·8 claims
- 1353US7122549B2Saframycins, analogues and uses thereofHARVARD COLLEGE·Filed 2004·Granted Oct 17, 2006·0 cites·60 claims
- 1448US8084478B2Substituted 5- phenylamino- 1, 3, 4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme A diacylglycerol acyltransferaseBUTLIN ROGER JOHN·Filed 2007·Granted Dec 27, 2011·0 cites·13 claims
- 1545US8735410B2Quinazoline derivatives as tyrosine kinase inhibitorsHALSALL CHRISTOPHER THOMAS·Filed 2006·Granted May 27, 2014·0 cites·3 claims
- 1645US2011092547A1Chemical compounds 979BIRCH ALAN MARTIN·Filed 2008·Application pending·0 cites
- 1744US2007043010A1Quinazoline derivativesASTRAZENECA UK LTD·Filed 2004·Application pending·0 cites
- 1843US2010137397A1Chemical CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1943US2009306133A1New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2042US2010317653A1Oxadiazole derivatives as dgat inhibitorsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2141US2009197926A1Benzimidazoles and their use for the treatment of diabetesBIRCH ALAN MARTIN·Filed 2007·Application pending·0 cites
- 2238US2010173958A1Compounds for the inhibition of dgat1 activityBENNETT STUART NORMAN LILE·Filed 2007·Application pending·0 cites
- 2338US2009124682A1Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory ActivityBIRCH ALAN MARTIN·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →